10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Sales | 298,845 | 245,893 | 146,313 | 71,085 | 0 |
| Cost of Goods | 58,468 | 61,033 | 28,661 | 10,560 | N/A |
| Gross Profit | 240,377 | 184,860 | 117,652 | 60,525 | N/A |
| Operating Expenses | 774,987 | 215,466 | 229,077 | 79,460 | 0 |
| Operating Income | -534,142 | -30,573 | -110,764 | -18,375 | N/A |
| Interest Expense | 1,682 | 3,079 | 2,409 | 811 | 0 |
| Other Income | 1,348 | 2,619 | 775 | 445 | 0 |
| Pre-tax Income | -534,476 | -31,033 | -112,398 | -18,741 | 0 |
| Income Tax | 8,255 | 218 | 87 | 21 | N/A |
| Net Income Continuous | -542,731 | -31,251 | -112,485 | -18,762 | N/A |
| Net Income | $-542,731 | $-31,251 | $-112,485 | $-18,762 | $N/A |
| EPS Basic Total Ops | -5.37 | -0.80 | -8.40 | -1.62 | N/A |
| EPS Basic Continuous Ops | -5.37 | -0.80 | -8.40 | -1.62 | N/A |
| EPS Diluted Total Ops | -5.37 | -0.80 | -8.40 | -1.62 | N/A |
| EPS Diluted Continuous Ops | -5.37 | -0.80 | -8.40 | -1.62 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.95 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-515,121 | $-23,507 | $-106,859 | $-14,070 | $N/A |